Product image of Montelukast För Barn Från 6 Till 14 År Accord (Montelukast) supplied by GNH India

Montelukast För Barn Från 6 Till 14 År Accord

Active Ingredient:
Montelukast
Origin:
EU

Montelukast För Barn Från 6 Till 14 År Accord (Montelukast)

Montelukast, the active ingredient in Montelukast För Barn Från 6 Till 14 År Accord, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is used to manage asthma and allergic rhinitis in children aged six to fourteen years.

GNH India supplies Montelukast För Barn Från 6 Till 14 År Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Montelukast acts on the leukotriene pathway to control chronic respiratory and allergic conditions in children.
  • Asthma: reduces the frequency of bronchoconstriction episodes and improves overall lung function.
  • Allergic rhinitis: alleviates nasal congestion, sneezing and itchy eyes associated with seasonal allergies.
  • Exercise‑induced bronchospasm: helps prevent airway narrowing triggered by physical activity.

How It Works

  • Montelukast selectively blocks cysteinyl leukotriene (CysLT1) receptors, preventing leukotriene D4 and related mediators from binding. This inhibition reduces inflammation, bronchoconstriction, and mucus secretion in the airways, thereby improving respiratory function and decreasing allergic symptoms.

Side Effects

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Abdominal pain: occasional discomfort.
  • Cough: transient irritation.
  • Nasopharyngitis: mild upper‑respiratory infection.
  • Rash: mild skin irritation.
  • Fever: low‑grade temperature elevation.

Serious or Rare Side Effects

  • Mood changes: depression or suicidal thoughts.
  • Allergic reactions: hives, swelling, or anaphylaxis.
  • Hepatotoxicity: abnormal liver enzymes.
  • Stevens‑Johnson syndrome: severe skin eruption.
  • Angioedema: rapid swelling of face or throat.
  • Blood dyscrasias: rare blood count abnormalities.

Precautions & Warnings

  • Montelukast should be used with awareness of specific safety considerations.
  • Dose adjustment: follow the prescriber's recommendation for age and weight.
  • Monitor mood: watch for signs of depression or suicidal ideation.
  • Liver function: assess hepatic enzymes in patients with known liver disease.
  • Drug interactions: review concomitant medications for potential CYP450 effects.
  • Pregnancy and lactation: discuss risks with a healthcare professional before use.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Montelukast may interact with other medicines that influence the CYP450 system or share similar therapeutic effects.

Major Interactions (Avoid)

  • Phenobarbital: may reduce montelukast plasma levels.
  • Rifampin: strong enzyme inducer that can lower efficacy.
  • St. John’s wort: may decrease drug exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential alteration of anticoagulant effect.
  • Zafirlukast or other leukotriene modifiers: additive pharmacologic effect.
  • Antidepressants: monitor for mood changes when combined.

Frequently Asked Questions

The product is indicated for maintenance therapy of asthma and for relief of symptoms of allergic rhinitis in children aged six to fourteen years. It helps reduce asthma attacks and eases nasal congestion, sneezing, and itchy eyes associated with allergies.

Montelukast blocks cysteinyl leukotriene (CysLT1) receptors, preventing leukotriene D4 and related inflammatory mediators from triggering bronchoconstriction, mucus production, and airway swelling. This results in improved breathing and reduced allergic inflammation.

The specific dose is determined by the prescribing healthcare professional based on the child’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Montelukast in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their doctor before starting therapy.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is especially useful for patients who need additional control of allergic components or who prefer a once‑daily tablet.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and keep out of reach of children.

The medication is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water unless the prescriber provides an alternative method.

Serious adverse events include mood changes such as depression or suicidal thoughts, severe allergic reactions like anaphylaxis, and rare skin conditions such as Stevens‑Johnson syndrome. Any concerning symptoms should be reported to a healthcare professional immediately.

Children with known hypersensitivity to montelukast or any component of the formulation should avoid the product. It is also contraindicated in patients who have experienced severe reactions to other leukotriene receptor antagonists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT